Eccrine squamous syringometaplasia as a manifestation of the recall phenomenon;Siringometaplasia escamosa ecrina como expresión del fenómeno de evocación

Actas Dermo-Sifiliograficas

Volumn 93, Issue 10, 2002, Pages 577-580

  Romero Gómez, Javier ^a   Vera Casaño, Ángel ^a   Martínez García, Silvestre ^a   Crespo Erchiga, Vicente ^a   Sanz Trelles, Andrés ^a   Acha García, Tomás ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

Eccrine squamous syringometaplasia; Recall phenomenon

Indexed keywords

DACTINOMYCIN; EPIRUBICIN; VINCRISTINE;

ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CASE REPORT; DERMATITIS; DRUG INDUCED DISEASE; ECCRINE SQUAMOUS SYRINGOMETAPLASIA; FEMALE; HUMAN; HUMAN TISSUE; METAPLASIA; MULTIMODALITY CANCER THERAPY; NEPHROBLASTOMA; PRESCHOOL CHILD; RASH; SKIN BIOPSY;

EID: 0036964977     PISSN: 00017310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-7310(02)76646-5     Document Type: Article

References (33)

1. Donaldson SS, Glick JM, Wilbur JR. Adriamycin activating a recall phenomenon after radiation therapy. Ann Intern Med 1974;81:407-8.
2. Castellano D, Hitt R, Cortés-Funes H, Romero A, Rodríguez-Peralto JL. Side effects of chemotherapy: case 2. Radiation recall reaction induced by gemcitabine. J Clin Oncol 2000;28:695-6.
3. Burdon J, Bell R, Sullivan J, Henderson M. Adriamycin-induced recall phenomenon 15 years after radiotherapy. JAMA 1978;239:931.
4. Ríos-Buceta L, Peñas PF, Dauden-Tello E, Fraga-Fernández J, Domínguez-Arciniega P, García-Díez A. Recall phenomenon with the unusual presence of eccrine squamous Syringometaplasia. Br J Dermatol 1995;133:630-2.
5. Burstein HJ. Sides effects of chemotherapy: case 2. Radiation recall dermatitis from gemcitabine. J Clin Oncol 2000;18:693-4.
6. D'Angio GJ, Farber S, Maddock CL. Potentiation of X-ray effects of actinomicin D. Radiology 1959;75:175-7.
7. Stelzer KJ, Griffin TW, Koh WJ. Radiation recall skin toxicity with bleomycin in a patient with Kaposi sarcoma related to acquired immune deficiency syndrome. Cancer 1993;71:1322-5.
8. Perz EA, Campbell DL, Ryu JK. Radiation recall dermatitis induced by edatrexate in a patient with breast cancer. Cancer Invest 1995;13:64-7.
9. Kharfan MA, Morgenzstern D, Markow AM, Barlett-Pandite L. Radiation recall dermatitis induced by methotrexate in a patient with Hodgkin's disease. Am J Clin Oncol 2000;23:531-3.
10. Fontana JA. Radiation recall associated with VP-16-213 therapy. Cancer Treat Rep 1979;63:224-5.
11. Sears ME. Erythema in areas of previous radiations in patients treated with hydroxyurea. Cancer Chemotherap Rep 1964;40:31-2.
12. Kellie SJ, Plowman PN, Malpas JS. Radiation recall and radiosensitization with alkylating agents. Lancet 1987;1:1149-50.
13. Philips KA, Urch M, Bishop JF. Radiation recall dermatitis in a patients treated with paclitaxel. J Clin Oncol 1995;13:305.
14. Parry BR. Radiation recall induced by tamoxifen. Lancet 1992;340:49.
15. Nemechek PM, Corder MC. Radiation recall association with vinblastina in a patient treated for Kaposi sarcoma related to acquired inmune deficiency syndrome. Cancer 1992;70:1605-6.
16. Lever WF. Adenoacanthoma of sweat glands. Arch Derm Syph 1947;56:157-71.
17. Freeman RG. On the pathogenesis of pseudoepitheliomatous hyperplasia. J Cutan Patol 1974;1:231-7.
18. Mehregan AH. Proliferation of sweat ducts in certain diseases of the skin. Am J Dermatopathol 1981;3:27-31.
19. Metcalf JS, Maize JC. Squamous syringometaplasia in lobular panniculitis and pyoderma gangrenosum. Am J Dermatopathol 1990;12:141-9.
20. Helton JL, Metcalf JS. Squamous syringometaplasia in association with annular elastolytic granuloma. Am J Dermatopathol 1995;17:407-9.
21. Muñoz E, Valks R, Fernández-Herrera J, Fraga J. Herpetic syringitis associated with eccrine aquamous syringometaplasia in HIV-positive patients. J Cutan Pathol 1997;24:425-8.
22. Akosa AB, Lampert IA. The sweat gland in graft-versushost-disease. J Pathol 1990;161:261-6.
23. Lerner TH, Barr RJ, Dolezal JF, Stagnone JJ. Syringomatous hyperplasia and eccrine squamous syringometaplasia associated with benoxaprofen therapy. Arch Dermatol 1987;123:1202-4.
24. Caputo R, Monti M, Ermarcora E, Carminati G, Gelmetti C, Gianotti R, et al. Cutaneous manifestations of tetrachlorodibenzo-p-dioxin in children and adolescents. J Am Acad Dermatol 1988;19:812-9.
25. Vargas-Díez E, Valks R, Fraga J, Fernández-Herrera J, GarcíaDíez A. Eccrine squamous syringometaplasia in a patient with phytophotodermatosis. Int J Dermatol 1998;37:715-7.
26. Sommer B, Haggedorn M, Wood F, Heenan P. Eccrine squamous syringometaplasia in the skin of children after burns. J Cutan Pathol 1998;25:56-8.
27. Valks R, Buezo GF, Daudén E, Fraga J, García-Díez A. Eccrine squamous syringometaplasia in intertriginous areas. Br J Dermatol 1996;134:984-6.
28. Johnson HL, Maibach HL. Drug excretion in human eccrine sweat. J Invest Dermatol 1971;56:182-8.
29. Valks R. Siringometaplasia escamosa ecrina. Actas Dermosifiliogr 2001;92:13-24.
30. Harris TJ, Fine JD, Berman RS, Murphy GF, Mihm MC. Neutrophilic eccrine hydradenitis. A distinctive type of neutrophilic dermatosis associated with myelogenous leukemia and chemotherapy. Arch Dermatol 1982;118:264-6.
31. Hurt MA, Halverson RD, Petr FC, Cooper JT, Friedman DJ. Eccrine squamous syringometaplasia. A cutaneous sweat gland reaction in the histologic spectrum of «chemoterapy-associated eccrine hidradenitis» and «neutrophilic eccrine hidradenitis». Arch Dermatol 1990;126:73-7.
32. Templeton SF, Solomon AR, Swearlick RA. Intradermal bleomycin injections into normal human skin. Arch Dermatol 1994;130:577-83.
33. Fenig E, Brenner B, Katz A, Sulkes J, Lapidot M, Schachter J, et al. Topical biafine and lipiderm for the prevention of radiation dermatitis: a randomized prospective trial. Oncol Rep 2001;8:305-9.